Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ester Del Signore

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Cancer Treatment Reviews|October 4, 2024
Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic developmentCarla Corvaja, Antonio Passaro, Ilaria Attili, et al.
Cancers|July 27, 2024
Post-Progression Analysis of <i>EGFR</i>-Mutant NSCLC Following Osimertinib Therapy in Real-World SettingsIlaria Attili, Carla Corvaja, Gianluca Spitaleri, et al.
Cancer Treatment Reviews|May 17, 2025
Dealing with KRAS G12C inhibition in non-small cell lung cancer (NSCLC) - biology, clinical results and future directionsIlaria Attili, Carla Corvaja, Pamela Trillo Aliaga, et al.
Lung Cancer (Amsterdam, Netherlands)|December 28, 2020
Surgery for small cell lung cancer: When and howMonica Casiraghi, Giulia Sedda, Ester Del Signore, et al.
Therapeutic Advances in Medical Oncology|May 3, 2014
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategiesChiara D'Antonio, Antonio Passaro, Bruno Gori, et al.
Frontiers in Oncology|November 9, 2020
Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional SurveyChiara Catania, Gianluca Spitaleri, Ester Del Signore, et al.
Cancers|August 29, 2024
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs"Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, et al.
Cancers|October 14, 2023
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a TargetGianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, et al.
Current Oncology (Toronto, Ont.)|May 26, 2023
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, et al.
Cancer Treatment Reviews|August 11, 2020
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published dataAntonio Passaro, Ilaria Attili, Stefania Morganti, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Cancer Treatment Reviews|October 4, 2024
Advancements in fourth-generation EGFR TKIs in EGFR-mutant NSCLC: Bridging biological insights and therapeutic developmentCarla Corvaja, Antonio Passaro, Ilaria Attili, et al.
Cancers|July 27, 2024
Post-Progression Analysis of <i>EGFR</i>-Mutant NSCLC Following Osimertinib Therapy in Real-World SettingsIlaria Attili, Carla Corvaja, Gianluca Spitaleri, et al.
Cancer Treatment Reviews|May 17, 2025
Dealing with KRAS G12C inhibition in non-small cell lung cancer (NSCLC) - biology, clinical results and future directionsIlaria Attili, Carla Corvaja, Pamela Trillo Aliaga, et al.
Lung Cancer (Amsterdam, Netherlands)|December 28, 2020
Surgery for small cell lung cancer: When and howMonica Casiraghi, Giulia Sedda, Ester Del Signore, et al.
Therapeutic Advances in Medical Oncology|May 3, 2014
Bone and brain metastasis in lung cancer: recent advances in therapeutic strategiesChiara D'Antonio, Antonio Passaro, Bruno Gori, et al.
Frontiers in Oncology|November 9, 2020
Fears and Perception of the Impact of COVID-19 on Patients With Lung Cancer: A Mono-Institutional SurveyChiara Catania, Gianluca Spitaleri, Ester Del Signore, et al.
Cancers|August 29, 2024
Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: "Shadows and Fogs"Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, et al.
Cancers|October 14, 2023
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a TargetGianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, et al.
Current Oncology (Toronto, Ont.)|May 26, 2023
Sustained Improvement in the Management of Patients with Non-Small-Cell Lung Cancer (NSCLC) Harboring ALK Translocation: Where Are We Running?Gianluca Spitaleri, Pamela Trillo Aliaga, Ilaria Attili, et al.
Cancer Treatment Reviews|August 11, 2020
Clinical features affecting survival in metastatic NSCLC treated with immunotherapy: A critical review of published dataAntonio Passaro, Ilaria Attili, Stefania Morganti, et al.
Pageof 4